ErbB3/HER3 does not homodimerize upon neuregulin binding at the cell surface

被引:126
作者
Berger, MB
Mendrola, JM
Lemmon, MA [1 ]
机构
[1] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Grad Grp Biochem & Mol Biophys, Philadelphia, PA 19104 USA
来源
FEBS LETTERS | 2004年 / 569卷 / 1-3期
关键词
heterodimer; epidermal growth factor; receptor; tyrosine kinase; signalling;
D O I
10.1016/j.febslet.2004.06.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To understand signaling by the neuregulin (NRG) receptor ErbB3/HER3, it is important to know whether ErbB3 forms homodimers upon ligand binding. Previous biophysical studies suggest that the ErbB3 extracellular region remains monomeric when bound to NRG. We used a chimeric receptor approach to address this question in living cells, fusing the extracellular region of ErbB3 to the kinase-active intracellular domain of ErbB1. The ErbB3/ErbB1 chimera responded to NRG only if ErbB2 was co-expressed in the same cells, whereas an ErbB4/ErbB1 chimera responded without ErbB2. We, therefore, suggest that ErbB3 is an obligate heterodimerization partner because of its inability to homodimerize. (C) 2004 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:332 / 336
页数:5
相关论文
共 36 条
  • [11] The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors
    Garrett, TPJ
    McKern, NM
    Lou, MZ
    Elleman, TC
    Adams, TE
    Lovrecz, GO
    Kofler, M
    Jorissen, RN
    Nice, EC
    Burgess, AW
    Ward, CW
    [J]. MOLECULAR CELL, 2003, 11 (02) : 495 - 505
  • [12] ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling
    GrausPorta, D
    Beerli, RR
    Daly, JM
    Hynes, NE
    [J]. EMBO JOURNAL, 1997, 16 (07) : 1647 - 1655
  • [13] EXPRESSION OF THE HUMAN EGF RECEPTOR WITH LIGAND-STIMULATABLE KINASE-ACTIVITY IN INSECT CELLS USING A BACULOVIRUS VECTOR
    GREENFIELD, C
    PATEL, G
    CLARK, S
    JONES, N
    WATERFIELD, MD
    [J]. EMBO JOURNAL, 1988, 7 (01) : 139 - 146
  • [14] INSECT CELL-EXPRESSED P180(ERBB3) POSSESSES AN IMPAIRED TYROSINE KINASE-ACTIVITY
    GUY, PM
    PLATKO, JV
    CANTLEY, LC
    CERIONE, RA
    CARRAWAY, KL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (17) : 8132 - 8136
  • [15] GUY PM, 1992, J BIOL CHEM, V267, P13851
  • [16] The ErbB receptors and their role in cancer progression
    Holbro, T
    Civenni, G
    Hynes, NE
    [J]. EXPERIMENTAL CELL RESEARCH, 2003, 284 (01) : 99 - 110
  • [17] The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation
    Holbro, T
    Beerli, RR
    Maurer, F
    Koziczak, M
    Barbas, CF
    Hynes, NE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (15) : 8933 - 8938
  • [18] BINDING OF NEU DIFFERENTIATION FACTOR WITH THE EXTRACELLULAR DOMAIN OF HER2 AND HER3
    HORAN, T
    WEN, J
    ARAKAWA, T
    LIU, NL
    BRANKOW, D
    HU, S
    RATZKIN, B
    PHILO, JS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (41) : 24604 - 24608
  • [19] Proxy activation of protein ErbB2 by heterologous ligands implies a heterotetrameric mode of receptor tyrosine kinase interaction
    Huang, GC
    Ouyang, XM
    Epstein, RJ
    [J]. BIOCHEMICAL JOURNAL, 1998, 331 : 113 - 119
  • [20] ISOLATION AND CHARACTERIZATION OF ERBB3, A 3RD MEMBER OF THE ERBB/EPIDERMAL GROWTH-FACTOR RECEPTOR FAMILY - EVIDENCE FOR OVEREXPRESSION IN A SUBSET OF HUMAN MAMMARY-TUMORS
    KRAUS, MH
    ISSING, W
    MIKI, T
    POPESCU, NC
    AARONSON, SA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (23) : 9193 - 9197